Pre-Conference Perspectives on Hematologic Malignancies

EP. 1: Pre-Conference Perspectives on Hematologic Malignancies

December 6th 2017

EP. 2: Hodgkin Lymphoma: Upfront Brentuximab Vedotin + AVD

December 6th 2017

EP. 3: New Data for Mantle Cell Lymphoma

December 6th 2017

EP. 4: NHL Studies: CAR T Therapy, Rituximab Maintenance, & PD-L1

December 6th 2017

EP. 5: Acute Myeloid Leukemia: Novel Targeted Therapies

December 6th 2017

EP. 6: AML Studies: FLT3 Inhibitors

December 6th 2017

EP. 7: AML Studies: BiTE Antibodies and Age for Transplant

December 6th 2017

EP. 8: KRd for High-Risk Smoldering Myeloma

December 6th 2017

EP. 9: Daratumumab for Smoldering Myeloma

December 6th 2017

EP. 10: Key Studies in Newly-Diagnosed Multiple Myeloma

December 6th 2017

EP. 11: Phase III Data for Relapsed/Refractory Myeloma

December 6th 2017

EP. 12: MRD Testing in Hematologic Malignancies

December 6th 2017

EP. 13: Q & A Session for Hematologic Malignancies

December 6th 2017

EP. 14: What You Need to Know: Hematologic Malignancies

December 6th 2017